[What's new in 2008 in kidney cancer?].
作者信息
Phé V, Rouprêt M, Lechevallier E, Patard J-J
机构信息
Service d'Urologie Hôpital Pitié-Salpétrière, Assistance Publique-Hôpitaux de Paris, Groupe Hospitalo-Universitaire Est, Faculté de médecine Pierre et Marie Curie, Université Paris VI, Paris, France.
出版信息
Prog Urol. 2009 May;19 Suppl 2:S56-64. doi: 10.1016/S1166-7087(09)73896-5.
The most innovating studies presented at the 2008 international conferences in the field of kidney cancer were selected. In localized kidney cancer, contrast-enhanced ultrasonography could be a new diagnostic tool. Many communications dealed with positive surgical margins and their consequences, and predictive factors of chronic kidney disease after nephrectomy. Robot-assisted laparoscopic nephrectomy seems to be a safe and effective technique. Mini-invasive treatments are promising. In metastatic kidney cancer, sunitinib was compared to IFN-alpha in first line treatment and survival data are now available. Everolimus could become the new standard after tyrosine kinase inhibitor failure.
Zotero 插件